Correlation Between Eliem Therapeutics and Entero Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Entero Therapeutics,, you can compare the effects of market volatilities on Eliem Therapeutics and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Entero Therapeutics,.
Diversification Opportunities for Eliem Therapeutics and Entero Therapeutics,
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Eliem and Entero is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Entero Therapeutics, go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Entero Therapeutics,
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 0.67 times more return on investment than Entero Therapeutics,. However, Eliem Therapeutics is 1.48 times less risky than Entero Therapeutics,. It trades about 0.04 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.06 per unit of risk. If you would invest 255.00 in Eliem Therapeutics on September 2, 2024 and sell it today you would earn a total of 49.00 from holding Eliem Therapeutics or generate 19.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 99.6% |
| Values | Daily Returns |
Eliem Therapeutics vs. Entero Therapeutics,
Performance |
| Timeline |
| Eliem Therapeutics |
| Entero Therapeutics, |
Eliem Therapeutics and Entero Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Entero Therapeutics,
The main advantage of trading using opposite Eliem Therapeutics and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Entero Therapeutics, vs. Tff Pharmaceuticals | Entero Therapeutics, vs. Eliem Therapeutics | Entero Therapeutics, vs. Inhibrx | Entero Therapeutics, vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| CEOs Directory Screen CEOs from public companies around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |